We are live on ! Find out more
LAB icon

Standard BioTools
LAB

66 hedge funds and large institutions have $89.1M invested in Standard BioTools in 2023 Q2 according to their latest regulatory filings, with 13 funds opening new positions, 11 increasing their positions, 25 reducing their positions, and 15 closing their positions.

New
Increased
Maintained
Reduced
Closed

0.57% more ownership

Funds ownership: 58.31% → 58.88% (+0.57%)

0% more funds holding in top 10

Funds holding in top 10: 2 → 2 (0)

1% less capital invested

Capital invested by funds: $89.9M → $89.1M (-$766K)

4% less funds holding

Funds holding: 69 → 66 (-3)

13% less first-time investments, than exits

New positions opened: 13 | Existing positions closed: 15

53% less call options, than puts

Call options by funds: $29K | Put options by funds: $62K

56% less repeat investments, than reductions

Existing positions increased: 11 | Existing positions reduced: 25

Holders
66
Holders Change
-3
Holders Change %
-4.35%
% of All Funds
1.04%
Holding in Top 10
2
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.03%
New
13
Increased
11
Reduced
25
Closed
15
Calls
$29K
Puts
$62K
Net Calls
-$33K
Net Calls Change
+$200K

Top Buyers

1
Balyasny Asset Management
Balyasny Asset Management
Illinois
+$4.15M
2
CC
Casdin Capital
New York
+$2.37M
3
Renaissance Technologies
Renaissance Technologies
New York
+$570K
4
SAM
Silverback Asset Management
North Carolina
+$98.7K
5
MCP
Mirador Capital Partners
California
+$94.7K

Top Sellers

1
Primecap Management
Primecap Management
California
-$2.52M
2
NIM
Needham Investment Management
New York
-$1.65M
3
Millennium Management
Millennium Management
New York
-$643K
4
D.E. Shaw & Co
D.E. Shaw & Co
New York
-$467K
5
Jane Street
Jane Street
New York
-$441K
Name Holding Trade Value Shares
Change 		Change in
Stake
CP
1
Caligan Partners
New York
$16.3M -$215K -108,879 -1%
ICM
2
Indaba Capital Management
California
$14.4M – – –
Neuberger Berman Group
3
Neuberger Berman Group
New York
$8.69M -$7.16K -3,627 -0.1%
Vanguard Group
4
Vanguard Group
Pennsylvania
$7.61M -$25.8K -13,078 -0.3%
Primecap Management
5
Primecap Management
California
$6.22M -$2.52M -1,276,656 -28%
Morgan Stanley
6
Morgan Stanley
New York
$5.88M -$300K -152,211 -5%
BFM
7
Boothbay Fund Management
New York
$4.44M – – –
Balyasny Asset Management
8
Balyasny Asset Management
Illinois
$4.06M +$4.15M +2,101,690 New
NIM
9
Needham Investment Management
New York
$3.93M -$1.65M -835,565 -29%
BlackRock
10
BlackRock
New York
$2.77M +$36.1K +18,290 +1%
CC
11
Casdin Capital
New York
$2.32M +$2.37M +1,200,000 New
JCP
12
Jennifer C. Price
$1.89M +$14.5K +7,346 +0.8%
HighTower Advisors
13
HighTower Advisors
Illinois
$1.52M -$407K -206,233 -21%
Geode Capital Management
14
Geode Capital Management
Massachusetts
$1.33M -$51.5K -26,101 -4%
Renaissance Technologies
15
Renaissance Technologies
New York
$1.21M +$570K +289,009 +86%
Millennium Management
16
Millennium Management
New York
$1.13M -$643K -325,844 -36%
SAM
17
Silverback Asset Management
North Carolina
$869K +$98.7K +50,000 +13%
D.E. Shaw & Co
18
D.E. Shaw & Co
New York
$663K -$467K -236,806 -41%
State Street
19
State Street
Massachusetts
$540K – – –
BCM
20
Bridgeway Capital Management
Texas
$409K – – –
Northern Trust
21
Northern Trust
Illinois
$337K +$1.75K +884 +0.5%
Rockefeller Capital Management
22
Rockefeller Capital Management
New York
$253K -$5.92K -3,000 -2%
PCH
23
Polar Capital Holdings
United Kingdom
$193K – – –
Bank of New York Mellon
24
Bank of New York Mellon
New York
$193K -$38.8K -19,642 -16%
Tudor Investment Corp
25
Tudor Investment Corp
Connecticut
$164K -$104K -52,468 -38%
1
2 3 4

LAB Hedge Fund Activity: Q2 2023 in Review

66 of the 6,369 institutional investors tracked by Wall St. Rank reported a position in Standard BioTools (LAB) for Q2 2023, worth a combined $89.1M — down 0.85% from $89.9M a quarter earlier.

Sellers outnumbered buyers: 15 funds closed out of LAB and 13 opened new positions — a net loss of 2 holders — while 25 trimmed existing stakes and 11 added.

The largest buyer was Balyasny Asset Management, opening a new position worth an estimated $4.15M. The largest seller was Primecap Management, cutting an estimated $2.52M.

  • 66 institutional investors held Standard BioTools (LAB) as of Q2 2023, down from 69 in Q1 2023.
  • Funds reported $89.1M of Standard BioTools stock for Q2 2023, down 0.85% quarter-over-quarter.
  • 13 funds opened new Standard BioTools positions in Q2 2023 and 15 closed out, a net change of -2 holders.
  • The largest Standard BioTools buyer in Q2 2023 was Balyasny Asset Management, an estimated $4.15M added.
  • The largest Standard BioTools seller in Q2 2023 was Primecap Management, an estimated $2.52M sold.

Based on aggregated 13F filings for Q2 2023.